Published in Neuroimage on November 07, 2007
Susceptibility-weighted imaging: technical aspects and clinical applications, part 2. AJNR Am J Neuroradiol (2009) 4.93
Susceptibility-weighted imaging: technical aspects and clinical applications, part 1. AJNR Am J Neuroradiol (2008) 4.57
Magnetic susceptibility mapping of brain tissue in vivo using MRI phase data. Magn Reson Med (2009) 3.00
Layer-specific variation of iron content in cerebral cortex as a source of MRI contrast. Proc Natl Acad Sci U S A (2010) 2.33
MRI in multiple sclerosis: current status and future prospects. Lancet Neurol (2008) 2.08
The contribution of myelin to magnetic susceptibility-weighted contrasts in high-field MRI of the brain. Neuroimage (2011) 1.68
Tracking iron in multiple sclerosis: a combined imaging and histopathological study at 7 Tesla. Brain (2011) 1.68
In vivo imaging of cortical pathology in multiple sclerosis using ultra-high field MRI. Neurology (2009) 1.64
On the contribution of deoxy-hemoglobin to MRI gray-white matter phase contrast at high field. Neuroimage (2009) 1.41
The contribution of chemical exchange to MRI frequency shifts in brain tissue. Magn Reson Med (2011) 1.34
High field MRI in the diagnosis of multiple sclerosis: high field-high yield? Neuroradiology (2009) 1.24
Quantitative susceptibility mapping differentiates between blood depositions and calcifications in patients with glioblastoma. PLoS One (2013) 1.18
Study of brain anatomy with high-field MRI: recent progress. Magn Reson Imaging (2010) 1.14
High-resolution phased-array MRI of the human brain at 7 tesla: initial experience in multiple sclerosis patients. J Neuroimaging (2009) 1.09
Quantitative oxygenation venography from MRI phase. Magn Reson Med (2013) 1.04
In vivo evidence of disseminated subpial T2* signal changes in multiple sclerosis at 7 T: a surface-based analysis. Neuroimage (2011) 1.03
Fast quantitative susceptibility mapping with L1-regularization and automatic parameter selection. Magn Reson Med (2013) 1.02
Gradient echo plural contrast imaging--signal model and derived contrasts: T2*, T1, phase, SWI, T1f, FST2*and T2*-SWI. Neuroimage (2012) 1.02
Effects of white matter microstructure on phase and susceptibility maps. Magn Reson Med (2014) 1.02
7 Tesla MR imaging of the human eye in vivo. J Magn Reson Imaging (2009) 1.00
7-Tesla susceptibility-weighted imaging to assess the effects of radiotherapy on normal-appearing brain in patients with glioma. Int J Radiat Oncol Biol Phys (2011) 0.99
Decreased brain venous vasculature visibility on susceptibility-weighted imaging venography in patients with multiple sclerosis is related to chronic cerebrospinal venous insufficiency. BMC Neurol (2011) 0.96
Phase contrast imaging in neonates. Neuroimage (2011) 0.92
Phase reconstruction from multiple coil data using a virtual reference coil. Magn Reson Med (2013) 0.88
Calibrated BOLD using direct measurement of changes in venous oxygenation. Neuroimage (2012) 0.86
Real diffusion-weighted MRI enabling true signal averaging and increased diffusion contrast. Neuroimage (2015) 0.82
Susceptibility-weighted imaging: current status and future directions. NMR Biomed (2016) 0.82
Imaging of stroke: a comparison between X-ray fluorescence and magnetic resonance imaging methods. Magn Reson Imaging (2012) 0.81
MAGPI: A framework for maximum likelihood MR phase imaging using multiple receive coils. Magn Reson Med (2015) 0.80
A Joint Acquisition-Estimation Framework for MR Phase Imaging. Inf Process Med Imaging (2015) 0.79
Combining phase images from array coils using a short echo time reference scan (COMPOSER). Magn Reson Med (2015) 0.78
Quantitative 7T phase imaging in premanifest Huntington disease. AJNR Am J Neuroradiol (2014) 0.77
High-field imaging of neurodegenerative diseases. Neuroimaging Clin N Am (2012) 0.77
Improving contrast to noise ratio of resonance frequency contrast images (phase images) using balanced steady-state free precession. Neuroimage (2010) 0.77
A comparison of phase imaging and quantitative susceptibility mapping in the imaging of multiple sclerosis lesions at ultrahigh field. MAGMA (2016) 0.76
An illustrated comparison of processing methods for MR phase imaging and QSM: combining array coil signals and phase unwrapping. NMR Biomed (2016) 0.76
Quantitative assessment of microvasculopathy in arcAβ mice with USPIO-enhanced gradient echo MRI. J Cereb Blood Flow Metab (2015) 0.76
Clinical 3-tesla FLAIR* MRI improves diagnostic accuracy in multiple sclerosis. Mult Scler (2016) 0.76
Methods for the computation of templates from quantitative magnetic susceptibility maps (QSM): Toward improved atlas- and voxel-based analyses (VBA). J Magn Reson Imaging (2017) 0.76
An improved FSL-FIRST pipeline for subcortical gray matter segmentation to study abnormal brain anatomy using quantitative susceptibility mapping (QSM). Magn Reson Imaging (2017) 0.76
A comprehensive numerical analysis of background phase correction with V-SHARP. NMR Biomed (2016) 0.75
Probing signal phase in direct visualization of short transverse relaxation time component (ViSTa). Magn Reson Med (2014) 0.75
Relationship between radiation dose and microbleed formation in patients with malignant glioma. Radiat Oncol (2017) 0.75
Characterizing the contrast of white matter and grey matter in high-resolution phase difference enhanced imaging of human brain at 3.0 T. Eur Radiol (2014) 0.75
Susceptibility weighted imaging (SWI). Magn Reson Med (2004) 8.58
7T vs. 4T: RF power, homogeneity, and signal-to-noise comparison in head images. Magn Reson Med (2001) 7.05
Imaging iron stores in the brain using magnetic resonance imaging. Magn Reson Imaging (2005) 5.83
Iron, brain ageing and neurodegenerative disorders. Nat Rev Neurosci (2004) 5.37
High-field MRI of brain cortical substructure based on signal phase. Proc Natl Acad Sci U S A (2007) 5.02
The role of magnetic susceptibility in magnetic resonance imaging: MRI magnetic compatibility of the first and second kinds. Med Phys (1996) 4.94
The effect of age on the non-haemin iron in the human brain. J Neurochem (1958) 4.83
Fast, automated, N-dimensional phase-unwrapping algorithm. Magn Reson Med (2003) 4.21
Magnetic susceptibility-weighted MR phase imaging of the human brain. AJNR Am J Neuroradiol (2005) 2.73
Establishing a baseline phase behavior in magnetic resonance imaging to determine normal vs. abnormal iron content in the brain. J Magn Reson Imaging (2007) 2.34
Enhanced gray and white matter contrast of phase susceptibility-weighted images in ultra-high-field magnetic resonance imaging. J Magn Reson Imaging (2003) 2.22
The correlation between phase shifts in gradient-echo MR images and regional brain iron concentration. Magn Reson Imaging (1999) 2.11
Rapid in vivo proton shimming. Magn Reson Med (1991) 1.84
Volume imaging with MR phased arrays. Magn Reson Med (1991) 1.84
Regional variation in brain capillary density and vascular response to ischemia. Brain Res (2001) 1.82
High-field magnetic resonance imaging of brain iron: birth of a biomarker? NMR Biomed (2004) 1.80
Extensive heterogeneity in white matter intensity in high-resolution T2*-weighted MRI of the human brain at 7.0 T. Neuroimage (2006) 1.78
MRI of brain iron. AJR Am J Roentgenol (1986) 1.76
Susceptibility-weighted imaging to visualize blood products and improve tumor contrast in the study of brain masses. J Magn Reson Imaging (2006) 1.70
Transferrin and iron in normal, Alzheimer's disease, and Parkinson's disease brain regions. J Neurochem (1995) 1.65
Myelin breakdown and iron changes in Huntington's disease: pathogenesis and treatment implications. Neurochem Res (2007) 1.63
Histochemical distribution of non-haem iron in the human brain. Acta Anat (Basel) (1992) 1.58
Iron misregulation in the brain: a primary cause of neurodegenerative disorders. Lancet Neurol (2003) 1.57
Rapid, fully automatic, arbitrary-volume in vivo shimming. Magn Reson Med (1991) 1.44
Intracranial calcification on gradient-echo phase image: depiction of diamagnetic susceptibility. Radiology (1996) 1.43
Phased array detectors and an automated intensity-correction algorithm for high-resolution MR imaging of the human brain. Magn Reson Med (1995) 1.39
Fast, fully automated global and local magnetic field optimization for fMRI of the human brain. Neuroimage (2002) 1.37
Metals in our minds: therapeutic implications for neurodegenerative disorders. Lancet Neurol (2004) 1.24
NMR relaxation times of blood: dependence on field strength, oxidation state, and cell integrity. J Comput Assist Tomogr (1987) 1.18
Iron and iron management proteins in neurobiology. Pediatr Neurol (2001) 1.18
An in vivo automated shimming method taking into account shim current constraints. Magn Reson Med (1995) 1.07
High resolution MRI of the deep gray nuclei at 8 Tesla. J Comput Assist Tomogr (1999) 1.06
Gliomas: correlation of magnetic susceptibility artifact with histologic grade. Radiology (1997) 1.04
Robust fully automated shimming of the human brain for high-field 1H spectroscopic imaging. Magn Reson Med (2006) 1.02
Demonstration of paramagnetic and diamagnetic cerebral lesions by using susceptibility weighted phase imaging (SWI). Z Med Phys (2006) 0.96
Susceptibility-based imaging of glioblastoma microvascularity at 8 T: correlation of MR imaging and postmortem pathology. AJNR Am J Neuroradiol (2004) 0.96
Tumor suppression by p53 is mediated in part by the antiangiogenic activity of endostatin and tumstatin. Sci STKE (2006) 0.93
[Prognosis in multiple sclerosis]. Schweiz Med Wochenschr (1997) 0.83
Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group. J Clin Oncol (2010) 14.79
Progressive multifocal leukoencephalopathy in a patient treated with natalizumab. N Engl J Med (2005) 7.04
Analysis of cancer metabolism by imaging hyperpolarized nuclei: prospects for translation to clinical research. Neoplasia (2011) 5.53
Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors. N Engl J Med (2015) 5.03
Hyperpolarized 13C lactate, pyruvate, and alanine: noninvasive biomarkers for prostate cancer detection and grading. Cancer Res (2008) 4.79
Abnormal brain development in newborns with congenital heart disease. N Engl J Med (2007) 4.55
Progression-free survival: an important end point in evaluating therapy for recurrent high-grade gliomas. Neuro Oncol (2008) 4.39
Metabolic imaging of patients with prostate cancer using hyperpolarized [1-¹³C]pyruvate. Sci Transl Med (2013) 4.23
Hyperpolarized C-13 spectroscopic imaging of the TRAMP mouse at 3T-initial experience. Magn Reson Med (2007) 4.13
Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis. Hum Mol Genet (2008) 3.93
Pathway and network-based analysis of genome-wide association studies in multiple sclerosis. Hum Mol Genet (2009) 3.92
Inequality in early childhood: risk and protective factors for early child development. Lancet (2011) 3.48
Q-ball reconstruction of multimodal fiber orientations using the spherical harmonic basis. Magn Reson Med (2006) 3.35
Double spin-echo sequence for rapid spectroscopic imaging of hyperpolarized 13C. J Magn Reson (2007) 3.35
Agenesis of the corpus callosum: genetic, developmental and functional aspects of connectivity. Nat Rev Neurosci (2007) 3.28
Prognostic factors for survival of patients with glioblastoma: recursive partitioning analysis. Neuro Oncol (2004) 3.25
Epidermal growth factor receptor variant III status defines clinically distinct subtypes of glioblastoma. J Clin Oncol (2007) 3.07
Role of extent of resection in the long-term outcome of low-grade hemispheric gliomas. J Clin Oncol (2008) 2.92
Phase II study of erlotinib plus temozolomide during and after radiation therapy in patients with newly diagnosed glioblastoma multiforme or gliosarcoma. J Clin Oncol (2008) 2.71
Quantitative in vivo magnetic resonance imaging of multiple sclerosis at 7 Tesla with sensitivity to iron. Ann Neurol (2008) 2.65
Combined magnetic resonance imaging and spectroscopic imaging approach to molecular imaging of prostate cancer. J Magn Reson Imaging (2002) 2.64
Early brain injury in premature newborns detected with magnetic resonance imaging is associated with adverse early neurodevelopmental outcome. J Pediatr (2005) 2.63
Differential sensitivity of glioma- versus lung cancer-specific EGFR mutations to EGFR kinase inhibitors. Cancer Discov (2012) 2.61
Diffusion tensor imaging: serial quantitation of white matter tract maturity in premature newborns. Neuroimage (2004) 2.58
A randomized trial of stress management for the prevention of new brain lesions in MS. Neurology (2012) 2.46
Registration-based approach for reconstruction of high-resolution in utero fetal MR brain images. Acad Radiol (2006) 2.43
Functional mapping-guided resection of low-grade gliomas in eloquent areas of the brain: improvement of long-term survival. Clinical article. J Neurosurg (2010) 2.42
Compressed sensing for resolution enhancement of hyperpolarized 13C flyback 3D-MRSI. J Magn Reson (2008) 2.39
Design of flyback echo-planar readout gradients for magnetic resonance spectroscopic imaging. Magn Reson Med (2005) 2.33
Unilateral putaminal CT, MR, and diffusion abnormalities secondary to nonketotic hyperglycemia in the setting of acute neurologic symptoms mimicking stroke. AJNR Am J Neuroradiol (2004) 2.22
Application of novel response/progression measures for surgically delivered therapies for gliomas: Response Assessment in Neuro-Oncology (RANO) Working Group. Neurosurgery (2012) 2.19
Evidence of elevated glutamate in multiple sclerosis using magnetic resonance spectroscopy at 3 T. Brain (2005) 2.17
Measurement of brain glutamate using TE-averaged PRESS at 3T. Magn Reson Med (2004) 2.16
Quantitative diffusion tensor MRI fiber tractography of sensorimotor white matter development in premature infants. Neuroimage (2005) 2.13
End point assessment in gliomas: novel treatments limit usefulness of classical Macdonald's Criteria. J Clin Oncol (2009) 2.13
MRI in multiple sclerosis: current status and future prospects. Lancet Neurol (2008) 2.08
Grey matter volume in a large cohort of MS patients: relation to MRI parameters and disability. Mult Scler (2011) 2.07
The Effect of Timing of Concurrent Chemoradiation in Patients With Newly Diagnosed Glioblastoma. Neurosurgery (2015) 2.06
Structural dissociation of attentional control and memory in adults with and without mild traumatic brain injury. Brain (2008) 2.06
Kinetic modeling of hyperpolarized 13C1-pyruvate metabolism in normal rats and TRAMP mice. J Magn Reson (2009) 2.05
Magnetic resonance imaging pattern in natalizumab-associated progressive multifocal leukoencephalopathy. Ann Neurol (2012) 2.05
13C-pyruvate imaging reveals alterations in glycolysis that precede c-Myc-induced tumor formation and regression. Cell Metab (2011) 2.05
Quantitative analysis of prostate metabolites using 1H HR-MAS spectroscopy. Magn Reson Med (2006) 2.04
Consensus on the role of human cytomegalovirus in glioblastoma. Neuro Oncol (2012) 2.02
Direct intracerebral delivery of cintredekin besudotox (IL13-PE38QQR) in recurrent malignant glioma: a report by the Cintredekin Besudotox Intraparenchymal Study Group. J Clin Oncol (2007) 2.01
Comparing the diagnosis of white matter injury in premature newborns with serial MR imaging and transfontanel ultrasonography findings. AJNR Am J Neuroradiol (2003) 2.01
Diffusion tensor imaging of mild traumatic brain injury. J Head Trauma Rehabil (2010) 2.00
Hyperpolarized 13C magnetic resonance metabolic imaging: application to brain tumors. Neuro Oncol (2010) 1.97
Serial quantitative diffusion tensor MRI of the premature brain: development in newborns with and without injury. J Magn Reson Imaging (2002) 1.96
Phase II study of aflibercept in recurrent malignant glioma: a North American Brain Tumor Consortium study. J Clin Oncol (2011) 1.92
3D compressed sensing for highly accelerated hyperpolarized (13)C MRSI with in vivo applications to transgenic mouse models of cancer. Magn Reson Med (2010) 1.92
Proton HR-MAS spectroscopy and quantitative pathologic analysis of MRI/3D-MRSI-targeted postsurgical prostate tissues. Magn Reson Med (2003) 1.89
Early childhood stimulation benefits adult competence and reduces violent behavior. Pediatrics (2011) 1.86
Multi-compound polarization by DNP allows simultaneous assessment of multiple enzymatic activities in vivo. J Magn Reson (2010) 1.84
Noninvasive detection of target modulation following phosphatidylinositol 3-kinase inhibition using hyperpolarized 13C magnetic resonance spectroscopy. Cancer Res (2010) 1.81
Seizure characteristics and control following resection in 332 patients with low-grade gliomas. J Neurosurg (2008) 1.79
Association between stressful life events and exacerbation in multiple sclerosis: a meta-analysis. BMJ (2004) 1.74
A low-frequency variant at 8q24.21 is strongly associated with risk of oligodendroglial tumors and astrocytomas with IDH1 or IDH2 mutation. Nat Genet (2012) 1.73
Association between pathological and MRI findings in multiple sclerosis. Lancet Neurol (2012) 1.70
Evaluation of lactate and alanine as metabolic biomarkers of prostate cancer using 1H HR-MAS spectroscopy of biopsy tissues. Magn Reson Med (2008) 1.69
The effect of psychosocial stimulation on cognition and behaviour at 6 years in a cohort of term, low-birthweight Jamaican children. Dev Med Child Neurol (2010) 1.69
Fast dynamic 3D MR spectroscopic imaging with compressed sensing and multiband excitation pulses for hyperpolarized 13C studies. Magn Reson Med (2010) 1.67
Preoperative prognostic classification system for hemispheric low-grade gliomas in adults. J Neurosurg (2008) 1.66
A phase II trial of erlotinib in patients with recurrent malignant gliomas and nonprogressive glioblastoma multiforme postradiation therapy. Neuro Oncol (2009) 1.66
Poor drug distribution as a possible explanation for the results of the PRECISE trial. J Neurosurg (2010) 1.65
Detection of early response to temozolomide treatment in brain tumors using hyperpolarized 13C MR metabolic imaging. J Magn Reson Imaging (2011) 1.65
Investigation of tumor hyperpolarized [1-13C]-pyruvate dynamics using time-resolved multiband RF excitation echo-planar MRSI. Magn Reson Med (2010) 1.64
Feasibility of using hyperpolarized [1-13C]lactate as a substrate for in vivo metabolic 13C MRSI studies. Magn Reson Imaging (2008) 1.64
Pulse sequence for dynamic volumetric imaging of hyperpolarized metabolic products. J Magn Reson (2008) 1.64